| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 76H76554PA |
| InChI Key | PGYDXVBZYKQYCS-VPWBDBDCSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H21Cl2NO |
| Molecular Weight | 314.26 |
| AlogP | 4.21 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 12.47 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 20.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Monoamine transporter inhibitor | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Attention Deficit Disorder with Hyperactivity | 2 | D001289 | ClinicalTrials |
| Depressive Disorder | 2 | D003866 | ClinicalTrials |
| Cocaine-Related Disorders | 1 | D019970 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297385 |
| DrugBank | DB05805 |
| EPA CompTox | DTXSID70173250 |
| FDA SRS | 76H76554PA |
| PubChem | 68470595 |
| SureChEMBL | SCHEMBL2996257 |